Intermediate for Tofacitinib. Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.
Product Name: 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine
CAS Number: 3680-69-1
Molecular Weight:  153.5707
Molecular Formula:  C6H4ClN3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.